MedCity News
JANUARY 29, 2025
Novo Nordisks type 2 diabetes drug Ozempic has expanded its label to include chronic kidney disease. The new FDA approval comes as makers of GLP-1 drugs work to expand the uses of these products. The post New FDA Approval Adds Chronic Kidney Disease to Ozempics Label appeared first on MedCity News.
PharmaVoice
JANUARY 29, 2025
Executive hiring shifts are often indicators of wider trends in the market. Here’s how the hiring landscape for pharma leaders is changing.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
PharmaTech
JANUARY 29, 2025
Pharmaceutical Technology spoke with Saharsh Davuluri, Vice-Chairman and Managing Director, Neuland Laboratories, to see how the push to sustainability is impacting contract manufacturers.
PharmaVoice
JANUARY 29, 2025
Vertex Pharmaceuticals’ non-opioid pain medication is up for FDA approval this week. Other drugmakers have found safer alternatives to expand the pain management landscape.
Advertiser: ZoomInfo
AI adoption is reshaping sales and marketing. But is it delivering real results? We surveyed 1,000+ GTM professionals to find out. The data is clear: AI users report 47% higher productivity and an average of 12 hours saved per week. But leaders say mainstream AI tools still fall short on accuracy and business impact. Download the full report today to see how AI is being used — and where go-to-market professionals think there are gaps and opportunities.
PharmaTech
JANUARY 29, 2025
Pharmaceutical Technology spoke with Adam Sherlock, CEO of Qinecsa, about the industry trends of 2024, the future technology agenda, and M&A prospects in 2025.
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
PharmaTech
JANUARY 29, 2025
The platform is live with full functionality for use by marketing authorization holders and national competent authorities to report drug supply information.
pharmaphorum
JANUARY 29, 2025
Lyfegen and EVERSANA have joined forces to help pharma companies navigate an increasingly complex global drug pricing and access environment
Pharmaceutical Technology
JANUARY 29, 2025
A proposed ban on PFAS chemicals is being challenged over concerns about potential supply chain disruption in the pharmaceutical industry.
pharmaphorum
JANUARY 29, 2025
Genetic testing specialist 23andMe has launched a strategic review that could result in a sale of the company.
Speaker: Jesse Hunter and Brynn Chadwick
Today’s buyers expect more than generic outreach–they want relevant, personalized interactions that address their specific needs. For sales teams managing hundreds or thousands of prospects, however, delivering this level of personalization without automation is nearly impossible. The key is integrating AI in a way that enhances customer engagement rather than making it feel robotic.
PharmaTech
JANUARY 29, 2025
Drug manufacturer Novo Nordisk said the approval establishes Ozempic as the most broadly indicated GLP-1 RA in its class.
Pharmaceutical Technology
JANUARY 29, 2025
The potential secretary for Health and Human Services has been forced to defend his previous anti-vaccine stances at his senate hearing.
Pharmaceutical Commerce
JANUARY 29, 2025
The 7,000 square-foot GMP facility will provide formulation development support, along with analytical testing services.
Pharmaceutical Technology
JANUARY 29, 2025
The deal includes an upfront payment of $250m, with the potential for an additional $752.5m in milestone payments.
Advertiser: ZoomInfo
ZoomInfo customers aren’t just selling — they’re winning. Revenue teams using our Go-To-Market Intelligence platform grew pipeline by 32%, increased deal sizes by 40%, and booked 55% more meetings. Download this report to see what 11,000+ customers say about our Go-To-Market Intelligence platform and how it impacts their bottom line. The data speaks for itself!
Pharmaceutical Commerce
JANUARY 29, 2025
In the first part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Alex Guillen, global pharma and life sciences director at Tive, outlines the technological obstacles that lie ahead for the industry this year.
Pharmaceutical Technology
JANUARY 29, 2025
Enhertu is projected to reach $13.9bn in sales by 2030, according to GlobalDatas Pharma Intelligence Center.
Pharmaceutical Commerce
JANUARY 29, 2025
The latest news for pharma industry insiders.
Pharmaceutical Technology
JANUARY 29, 2025
Lyndra Therapeutics has announced the immediate appointment of Adam Sayer as its new president and CEO, succeeding Jessica Ballinger.
Speaker: Kevin Burke
AI is reshaping marketing and sales, empowering professionals to work smarter, faster, and more effectively. This webinar will provide a practical introduction to AI, focusing on its current applications, transformative potential, and strategies for successful implementation in your organization. Using real-world examples and actionable insights, we’ll examine how businesses are leveraging AI to increase efficiency, enhance personalization, and drive measurable results.
pharmaphorum
JANUARY 29, 2025
RFK Jr is unfit to lead the Department of Health and Human Services (HHS), according to members of his own family.
Pharmaceutical Technology
JANUARY 29, 2025
Sonnet BioTherapeutics has received a patent from the European Patent Office (EPO) for its fully human albumin binding (FHAB) technology.
pharmaphorum
JANUARY 29, 2025
The EMA has abandoned X for Bluesky, saying Elon Musk's social media platform "no longer suits our communication needs.
Pharmaceutical Technology
JANUARY 29, 2025
The approval solidifies Novo Nordisks Ozempic as the most broadly indicated GLP-1RA in the US.
Advertiser: ZoomInfo
Incorporating generative AI (gen AI) into your sales process can speed up your wins through improved efficiency, personalized customer interactions, and better informed decision- making. Gen AI is a game changer for busy salespeople and can reduce time-consuming tasks, such as customer research, note-taking, and writing emails, and provide insightful data analysis and recommendations.
Pharmaceutical Representative Training
JANUARY 29, 2025
Biosimilars: The Future of Affordable Biologic Therapies Biologics are some of the most expensive forms of therapy in modern healthcare. These high prices are the result of multiple factors: theyre derived from living organisms making them sensitive and complex for both manufacturers and patients, research requires advanced technology to test for safety and effectiveness, and theyre in high demand without much competition.
Pharmaceutical Technology
JANUARY 29, 2025
The FDA has granted RMAT designation to Beacon Therapeutics gene therapy, laru-zova, for treating X-linked retinitis pigmentosa (XLRP).
Pharmaceutical Representative Training
JANUARY 29, 2025
Resolving The Biggest Problems in Healthcare: Medicare Expenses, Prior Authorization, and Physician Burnout The United States has high healthcare spending and inequitably distributed unfavorable health outcomes compared to other high income countries. The access to higher quality physician care has been challenged by the Medicare pay cuts physicians have experienced over the past.
Pharma Marketing Network
JANUARY 29, 2025
Introduction The pharmaceutical industry is transforming at lightning speed. In 2025, pharmaceutical trends are redefining how brands connect with healthcare professionals (HCPs), patients, and stakeholders. Marketers must adapt to cutting-edge technology, personalized engagement, and regulatory shifts to stay ahead. But what exactly is shaping the future of pharma marketing this year?
Advertisement
What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.
Pharmaceutical Representative Training
JANUARY 29, 2025
Introduction The changing pharmaceutical sales landscape holds the promise of a metamorphosis that is now being augmented by digital technology and shifting market dynamics. At the core, e-detailing has created a 75% increase in digital engagement during this time of transformation compared to traditional methods of reaching HCPs. And this digital journey has only begun.
PharmExec
JANUARY 29, 2025
Approval was based on results from the Phase IIIb FLOW trial, which demonstrated a 24% relative risk reduction in kidney disease, kidney failure, and cardiovascular death in patients treated with Ozempic.
Pharmacy Times
JANUARY 29, 2025
Kathy Campbell, PharmD, shares her experiences helping 4 generations of patients.
Expert insights. Personalized for you.
243 
Let's personalize your content